Cbd And Hemp

NutraWomen Wednesday: Paola Fernandez, Founder and CEO of High Hemp

25-May-2022 By Danielle Masterson

While working at her father’s cigar company, Paola Fernandez invented a ‘natural’ alternative to tobacco-based rolling paper. In 2016, High Hemp was born and sells its flagship hemp wraps along with CBD gummies and tinctures. In under 5 years, Fernandez...

CV Sciences’ sales decline, but cost cutting keeps losses in check

16-May-2022 By Hank Schultz

CV Sciences Inc. sales declined slightly in the first quarter, but cost containment helped trim the company’s operating loss.

Radicle Science highlights findings from large CBD study

09-May-2022 By Danielle Masterson

The company collected data directly from thousands of participants in their real world environment.

FDA slams Delta-8 THC sellers over claims

04-May-2022 By Hank Schultz

FDA came down hard on purveyors of Delta-8 THC and CBD products that were making disease claims on the substances. The Agency also reiterated the reasons it believes Delta-8 is not a suitable ingredient for products marketed as supplements.

Thousands of additional CBD products added to FSA public list

28-Apr-2022 By Liza Laws

Thousands of CBD products have been added to the Food Standards Agency’s (FSA) public list this week allowing them to remain on the market.

NutraCast: Evo Hemp joins 40-Acre Co-Op to level farming opportunity

22-Apr-2022 By Danielle Masterson

When you picture a farmer, who comes to mind?

CBD list chaos continues as FSA extends deadline to allow more companies to seek approval

22-Apr-2022 By Liza Laws

The deadline for companies wanting to submit its CBD products to be approved for sale has been extended by the Food Standards Agency (FSA).

CV Sciences reports 18% revenue drop for ‘challenging’ 2021

04-Apr-2022 By Stephen Daniells

San Diego-based CV Sciences, one of the bell-weather companies in the hemp and CBD space, has reported a decline in revenues for the past financial year, but new initiatives have positioned the company for long-term growth, says its CEO.

FDA, FTC slap seven CBD firms with COVID-19 warning letters

01-Apr-2022 By Hank Schultz

Seven marketers of CBD products received warning letters for making COVID-19 treatment claims as part of the ongoing joint FDA/FTC enforcement action.

Best companies will prevail as CBD market goes through painful winnowing, CEO says

24-Feb-2022 By Hank Schultz

The hemp/CBD market is going through a reckoning but ultimately will emerge in a stronger position, said the head of one of few publicly traded companies in the sector.

NPA submits citizen’s petition demanding resolution on CBD issue

22-Feb-2022 By Hank Schultz

The Natural Products Association has filed a citizen’s petition calling for FDA to either rule that CBD is a legal dietary ingredient or to make a rule allowing enforcement discretion on the substance.

FDA approves IND application for CBD product

24-Jan-2022 By Danielle Masterson

Researchers hope CBD could help combat opioid use disorder, but what does this IND mean for the supplement industry?

HempFusion Wellness announces GRAS status, seeks high ground in anticipation CBD regulatory logjam breakup

13-Jan-2022 By Hank Schultz

HempFusion Wellness has announced that its proprietary CBD-containing extract has achieved GRAS status via an expert panel convened by the company.

Canadian firm Relevium struggles with direction as restriction placed on stock trades

23-Dec-2021 By Hank Schultz

Canadian firm Relevium Technologies says it will file its belated financial statements by the end of January 2022, which would lift a ban placed by regulators on sales of stock by the company’s management.

Industry sounds alarm over Oregon’s proposed restrictions on hemp/CBD products

15-Dec-2021 By Hank Schultz

New rules proposed in Oregon that would see restrictions placed around the sale most full spectrum hemp extracts have sounded alarm bells in the hemp/CBD industry. Stakeholders are scrambling to respond before the rules go into effect, which could be...

USP commentary sounds safety, quality alarm on delta-8 THC

03-Dec-2021 By Hank Schultz

The United States Pharmacopeia (USP) has published a commentary raising potential safety and quality control concerns about the delta-8 THC products flooding the market. The document also raised issues with other cannabinoids that are being isolated...

Expanding FDA's tool box, fending off state laws among priorities laid out at CRN meeting

21-Oct-2021 By Hank Schultz

CRN president and CEO Steve Mister laid out four priorities for the supplement industry at a meeting yesterday. Among the highlights were to prepare for state based regulations and strengthening self regulation.

World's 5th biggest economy now fully open to hemp/CBD products

07-Oct-2021 By Hank Schultz

California Gov. Gavin Newsom has signed a bill into law making hemp/CBD supplements and foods legal after an unsettled period in which the state health department was following a federal lead in ruling that CBD was not a legal dietary ingredient.

M&A ferment continues in CBD space with new deals

04-Oct-2021 By Hank Schultz

The tide of acquisition and diversification in the hemp/CBD space continues to rise with two deals announced recently.

Elderberry supplement sales skyrocketed to $320 million in 2020: ABC report

15-Sep-2021 By Stephen Daniells

Sales of herbal supplements in the US grew by a record-breaking 17.3% in 2020, with elderberry supplements surging to almost $320 million in the combined mainstream and natural channels.

CDC, FDA issue warnings about delta-8 THC safety

15-Sep-2021 By Hank Schultz

US federal regulatory agencies have issued warnings on the availability of delta-8 THC, saying reports of almost 150 recent emergency room visits have mentioned the substance.

California Gov. Newsom expected to sign hemp bill

13-Sep-2021 By Hank Schultz

The California Legislature has passed a bipartisan bill to establish rules for the production and marketing of CBD/hemp products. Proponents expect Gov. Gavin Newsom to sign the bill into law before the Oct. 10 deadline.

Guest article

NPA: Setting safety limit on CBD key part of regulatory process

08-Sep-2021 By Daniel Fabricant, PhD, Natural Products Association

NPA president and CEO Daniel Fabricant, PhD, argues that FDA does not need new authorities to regulate the CBD market and that determining a safe daily intake level for the substance should be an integral part of that process.

CBD/cannabis cosmetics, supplements firm scores important Colombian license

08-Sep-2021 By Hank Schultz

A Canadian CBD cosmetics, supplements and medical cannabis product company has received an important license from the government of Colombia, where its grow operations are located.

Mile High Labs says new certifications underpin quality, manufacturing reliability

03-Sep-2021 By Hank Schultz

One of the highest capacity CBD manufacturers in the business is bolstering its quality bona fides to go with a high profile partnership announced earlier this summer.

Guest article

CRN: Don’t Sell Out DSHEA for CBD

25-Aug-2021 By By Steve Mister, President & CEO, Council for Responsible Nutrition

We all want an expedient solution to the stalemate with FDA over the legal status of cannabidiol (CBD), but the call to allow FDA to set a maximum safe level for CBD is antithetical to the law governing dietary supplements, DSHEA.

FDA rejects two NDI filings on full spectrum hemp extracts

11-Aug-2021 By Hank Schultz

The US Food and Drug Administration has rejected two New Dietary Ingredient Notifications for CBD ingredients. Industry stakeholders said the fact of the rejections and some of wording used in the letters makes it clear that new legislation is likely...

Verdant Nature and CReDO Science team up to develop endocannabinoid products

29-Jul-2021 By Danielle Masterson

The union will bring formulation guidance to clients who want to manufacture CBD products.

Israeli firm claims to have cracked plant tissue production code with polyphenol, cannabinoid ingredients

19-Jul-2021 By Hank Schultz

Israeli technology firm BioHarvest Sciences claims to have cracked the cell tissue production code as it brings the first fruits of its labor to market — a resveratrol-heavy offering made from cells taken from the skin of red grapes. Cannabinoids...

Schumer bill mandates legal pathway for CBD supplements, directs FDA to set safe upper exposure limit

15-Jul-2021 By Hank Schultz

A bill put forward by Senate Majority leader Chuck Schumer, D-NY, to decriminalize marijuana includes language on CBD that has been welcomed by supplement industry stakeholders.

Cannabinoid fermentation specialist eyes Mexican market

12-Jul-2021 By Hank Schultz

The advent of a strategic patent has put formulation specialist Biomedican on course to fundamentally alter the cannabinoid supply picture, the company claims. In addition, a Mexican court ruling has opened up opportunities south of the border.

‘Full spectrum CBD’ means being honest about the THC content, manufacturer says

06-Jul-2021 By Hank Schultz

Not shying away from the THC content is the best way to offer a ‘full spectrum’ CBD product, a Kentucky-based manufacturer advocates.

Hemp advocates say recent FDA communique makes need for legislation even more pressing

01-Jul-2021 By Hank Schultz

The publication of a recent FDA priorities list that omitted the hemp/CBD question is a reminder that a legislative solution is the only practical way forward for a regulatory resolution for these ingredients, advocates say.

The blurred lines of the legality of Delta-8

22-Jun-2021 By Danielle Masterson

Months ago, many may not have even been aware of the existence of this cannabis compound. Today, Delta-8 is the fastest-growing category of hemp products, with US sales of products listing Delta-8 jumping 144% from a year earlier, according to cannabis...

The challenges with CBD for sports nutrition

17-Jun-2021 By Shane Starling

The CBD sports nutrition sector had its game significantly boosted in 2018 when the World Anti-Doping Agency (WADA) removed the hemp-derived cannabinoid from its list of banned performance-enhancing substances – the market duly took off.

COVID-19 and legal chaos dent CBD market – but Congress and a stronger economy offer hope

16-Jun-2021 By Shane Starling

The COVID-19 pandemic and ongoing legal quagmire surrounding CBD supplements and foods in the US have knocked what was a booming category – along with scarce science and raw material pricing and QC concerns – but the sector is looking to economic and...

cbdMD exec says future bright for brands with enough cash and right ethos

11-Jun-2021 By Hank Schultz

Despite a pessimistic outlook for the state of the CBD market, the CEO of a leading brand said there’s plenty of opportunity for companies committed to doing things the right way.

Myconic Capital Corp Capital Corp acquires KGK Science in $16.5 million deal

28-May-2021 By Hank Schultz

Contract research organization KGK Science Inc. will be acquired by Canadian investment issuer Myconic Capital Corp., it was announced yesterday. The deal is valued at as much as $16.5 million.

Bipartisan Senate CBD bill introduced

19-May-2021 By Hank Schultz

A US Senate bill to specifically allow the use of CBD and other hemp derivatives in dietary supplements and foods has been introduced with bipartisan sponsorship. The bill also enjoys broad support within the industry.

FTC targets another CBD marketer for unsubstantiated disease claims

18-May-2021 By Hank Schultz

A marketer of CBD products has agreed in a Federal Trade Commission administrative proceeding to cease making unsubstantiated disease treatment claims and pay more than $30,000 in consumer redress.

Introduction of Senate hemp market bill expected soon

17-May-2021 By Hank Schultz

A Senate version of a bill legalizing CBD as a dietary ingredient is reportedly slated to be introduced soon, perhaps as early as this week.

CV Sciences’ revenue plummets, reflecting overall contraction of CBD market

14-May-2021 By Hank Schultz

CBD products manufacturer CV Sciences has recorded a sharp decline in revenue, mirroring reports of an overall contraction in the market for hemp extract products.

CBD industry consolidation continues with manufacturing facility sale

05-May-2021 By Hank Schultz

In a sign of further consolidation within the CBD/hemp products industry, THC Farmaceuticals Inc has announced it has acquired a contract manufacturer in Southern California.

CBD watchdog finds 25% of products don’t test for microbials, pesticides, or heavy metals

27-Apr-2021 By Danielle Masterson

A report from a watchdog group found found that just 42% of CBD brands tested all their products for potency. Additionally, the vast majority of products tested were outside the limits of acceptable variance.

CV Sciences, Alkemist Labs team up with NIST to improve hemp/CBD testing

14-Apr-2021 By Hank Schultz

Leading hemp/CBD firm CV Sciences is partnering with Alkemist Labs and a government agency to improve the state of the art in cannabinoids testing.

KD Pharma expands CBD manufacturing capability with acquisition

12-Apr-2021 By Hank Schultz

Fish oils supplier KD Pharma has moved more aggressively into the cannabinoid space with the acquisition of the manufacturing assets of a Swiss CBD and phyotextract specialist firm, the company announced today.

Editor's Spotlight: Startup Focus

Rugby warriors tackle cannabinoid concerns with CBD startup

12-Apr-2021 By Nikki Hancocks

Two professional rugby players have created a startup selling third-party tested CBD supplements that give elite athletes and everyday consumers peace of mind over cannabinoid content

HempFusion bets on success with major FDM partner, 'digital relaunch' to drive brand

07-Apr-2021 By Hank Schultz

HempFusion, a manufacturer of CBD-containing ingestible and topical products, said a successful initial public offering and a refocus of its digital sales efforts will position the brand to become one of the major hemp/CBD players in 2021.

Santé Labs offers liposomal cannabinoid delivery technology to market

05-Apr-2021 By Hank Schultz

Texas delivery technology development firm Santé Laboratories is opening up its cannabinoid delivery system to brand holders. The approach has been validated with a direct to consumer control brand called RESET Bioscience.

Colorado unveils plan to bolster state support of hemp industry

30-Mar-2021 By Hank Schultz

The state of Colorado aims to remain a leader in the hemp industry, Gov. Jared Polis said at an industry event last week. He announced the release of a detailed state plan for the industry at the meeting, which includes scientific support, data sharing,...